Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin
- PMID: 9713360
- DOI: 10.1002/(SICI)1096-9896(199805)185:1<53::AID-PATH45>3.0.CO;2-F
Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin
Abstract
Undifferentiated carcinomas and osteoclast-like giant cell tumours of the pancreas commonly contain foci of neoplastic ductal glands. To test the hypothesis that undifferentiated carcinomas and osteoclast-like giant cell tumours have a ductal origin, the immunocytochemical cytokeratin pattern and the frequency and type of Ki-ras mutations at colon 12 were studied in a series of 17 undifferentiated carcinomas and two osteoclast-like giant cell tumours. The cytokeratin features of undifferentiated carcinomas and osteoclast-like giant cell tumours were compared with those found in 10 ductal adenocarcinomas, 20 acinar cell carcinomas, 25 neuroendocrine tumours, and 15 solid-pseudopapillary tumours. All undifferentiated carcinomas and osteoclast-like giant cell tumours stained with at least one cytokeratin antibody, and 13/19 of them with antibodies against cytokeratins 7, 8, 18, and 19. The latter cytokeratins were expressed in all ductal adenocarcinomas, but only in 15/20 acinar cell carcinomas, 2/25 neuroendocrine tumours, and 1/15 solid-pseudopapillary tumours. In addition to cytokeratin, 15/19 undifferentiated carcinomas/osteoclast-like giant cell tumours were positive for vimentin. Ki-ras mutations at codon 12 were found in 10 undifferentiated carcinomas and one osteoclast-like giant cell tumour from which DNA could be successfully amplified. The Ki-ras mutation patterns were analysed in six tumours and corresponded to those typical of ductal adenocarcinomas. In tumours with ductal and anaplastic components, both components revealed identical mutation patterns. From these findings, it is concluded that both undifferentiated carcinomas and osteoclast-like giant cell tumours belong to the pancreatic tumours that show a ductal phenotype. Since undifferentiated carcinomas and osteoclast-like giant cell tumours share the same cytokeratin and Ki-ras features, they are probably derived from the same cell lineage.
Similar articles
-
Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study.Arch Pathol Lab Med. 1998 Mar;122(3):266-72. Arch Pathol Lab Med. 1998. PMID: 9823867 Review.
-
Origin of giant cells in osteoclast-like giant cell tumors of the pancreas.Hum Pathol. 2000 Oct;31(10):1223-9. doi: 10.1053/hupa.2000.18491. Hum Pathol. 2000. PMID: 11070115
-
Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.Am J Pathol. 1993 Sep;143(3):685-98. Am J Pathol. 1993. PMID: 8362971 Free PMC article.
-
p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.Lab Invest. 1996 Jan;74(1):279-89. Lab Invest. 1996. PMID: 8569192
-
K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.Am J Surg Pathol. 1998 Oct;22(10):1247-54. doi: 10.1097/00000478-199810000-00010. Am J Surg Pathol. 1998. PMID: 9777987 Review.
Cited by
-
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?Ther Adv Med Oncol. 2024 Jul 26;16:17588359241265213. doi: 10.1177/17588359241265213. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39072242 Free PMC article. Review.
-
A pancreatic anaplastic carcinoma of spindle-cell form.Int J Pancreatol. 1999 Dec;26(3):201-4. doi: 10.1385/IJGC:26:3:201. Int J Pancreatol. 1999. PMID: 10732298
-
Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.World J Gastroenterol. 2014 Jun 28;20(24):7830-48. doi: 10.3748/wjg.v20.i24.7830. World J Gastroenterol. 2014. PMID: 24976721 Free PMC article. Review.
-
Acinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology.Front Med (Lausanne). 2015 Jun 15;2:41. doi: 10.3389/fmed.2015.00041. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26137463 Free PMC article. Review.
-
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5947-52. doi: 10.1073/pnas.0601273103. Epub 2006 Apr 3. Proc Natl Acad Sci U S A. 2006. PMID: 16585505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials